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An appendix of 24 key refer-
ences is available online.
See related article on page 511. Postoperative new-onset atrial fibrillation (PAF) remains the mostcommon and vexing problem confronting cardiac surgeons. It afflictsas many as 40% of patients undergoing coronary and valve surgeryand has been refractory to many attempted methods of prevention,both pharmacologic and nonpharmacologic. In this issue of the Jour-nal, Melo and colleagues1 have described a simple, quick, and effec-
tive adjunct procedure applied at the time of the operation that appears to halve the
incidence of PAF.
Although these authors have elegantly described a method that resulted in a 58%
reduction in the incidence of PAF, what is most interesting is that neither this study
nor any of those that have preceded it over the last 40 years has demonstrated a
prophylaxis that completely prevents PAF. Why is this? Most likely it is our poor
understanding of the mechanism underlying PAF: we simply do not know what
causes this phenomenon and therefore have been unable to make meaningful and
effective progress against it.
A review of electrophysiologic basics should prove helpful. Atrial fibrillation is
a reentrant arrhythmia. For any reentrant arrhythmia to occur, 2 conditions must
exist: there must be an initiating event that sets up the reentrant circuit, and there
must be a substrate capable of maintaining the arrhythmia. First, let us consider
initiation.
Initiation of reentry occurs when excitable tissue demonstrates unidirectional
conduction block and slow conduction. Unidirectional block means that an excita-
tion wave can no longer penetrate tissue in an orthograde manner yet can progress
through it in a retrograde direction. This is typically the result of prolonged
refractoriness as the excitation wave encounters cells that have not yet fully
recovered excitability. Slow conduction indicates that the progress of an excitation
wave is hindered long enough to permit abnormal tissue to recover excitability,
usually setting the stage for retrograde reentry of the excitation wave. This is
indicated in Figure 1, a classical example of reentry occurring in the end branches
of a Purkinje fiber as it ramifies onto a strand of ventricular muscle. This can also
occur in normal atrial tissue, as shown in Figure 2, which has many natural
ultrastructural branches and joinings.
Can reentry initiate in the postsurgical atrium? Unidirectional conduction block
is not difficult to demonstrate because there is a rather large degree of dispersion of
refractoriness, even in normal tissue.2,3 It is therefore not difficult to imagine how
a properly timed impulse might encounter refractory tissue in some patches of tissue
and block, whereas other areas would be fully excitable and conduct. Frequent
premature atrial contractions and bursts of atrial tachycardia are known to precede
bouts of PAF4 and are the likely agents that set up unidirectional block. An
interesting question for Melo and colleagues is whether ventral cardiac denervation
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altered the incidence of premature contractions, which
might have been an important salutary effect of their pro-
cedure.
Slow conduction, which results from a decrease in the
degree of cell-cell coupling, a diminution in the rapid in-
ward sodium current INa, is quite unusual in normal atrial
tissue. Recently, as shown in Figure 3, we have demon-
strated that the inflammatory mediator arachidonic acid can
reversibly depress conduction up to 60% less than baseline
in otherwise normal canine and human atrial tissues.5 This
suggests that the inflammatory state that appears after the
operation might in fact alter the underlying atrial electro-
physiology in a way that slow conduction might appear.
This is supported by the findings of several studies that have
shown that inflammatory markers, although generally in-
creased after cardiopulmonary bypass, are particularly in-
creased in those patients with PAF.6
But initiation is not sufficient; once PAF appears, it must
be maintained. For PAF to self-perpetuate, the excitation
wavelength of the reentrant circuit must be small enough to
fit within the physical confines of the affected tissue. Exci-
tation wavelength, defined in centimeters as the product of
conduction velocity (in centimeters per second) and refrac-
tory period (in seconds), typically ranges from 14 to 18 cm
in the normal atrium. However, it has been shown in the
chronically fibrillating atrium that conduction velocity is
normal, yet the refractory period is greatly shortened.7 As
shown above in Figure 3, we have already shown that
inflammation decreases conduction velocity in normal atrial
tissue.5 But further analysis of Figure 3 reveals that this
effect was seen only in the direction transverse to the
muscle fiber long axis; there was no effect parallel to the
long axis. This suggested to us that there was a change only
in transverse cell-cell coupling rather than a change in the
global properties of either depolarizing sodium ion currents
or repolarizing potassium currents. In support of this idea,
we have also demonstrated that the topical application of
steroidal and nonsteroidal anti-inflammatory drugs can pre-
vent fibrillation in an animal model of sterile talc pericar-
ditis.8 Exactly which agent of the inflammatory cascade is to
blame and exactly by what mechanism remains yet un-
known.
The mechanism by which the method of Melo and col-
leagues1 prevents PAF is not clear, and the authors mention
that our knowledge about the type of axons destroyed by
Figure 1. Reentry in the end strand of a Purkinje fiber.
Figure 2. Normal atrial muscle demonstrating multiple branches
and joinings.
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their procedure is quite limited. It is logical to expect,
however, that ventral cardiac denervation produces a car-
diac sympathectomy because the importance of sympathetic
outflow has been highlighted as a possible cause of PAF.9
Of course, it is possible that ventral denervation results in a
protective parasympathectomy because vagal stimulation
(or acetylcholine infusion) has been used for many years in
the laboratory to produce atrial fibrillation.
In summary, PAF likely results from postsurgical
changes in the atrium that render it susceptible to both the
initiation and maintenance of a reentrant arrhythmia. The
causes are still not completely defined, although inflamma-
tory changes are certainly suspect. The ventral cardiac de-
nervation technique of Melo and colleagues1 appears to be
easy, quick, safe, and effective at reducing the incidence of
PAF, without the addition of new or harmful drugs to the
postoperative regimen. Elucidation of its exact mechanism
of action will have to await a better understanding of the
underlying pathophysiology of this disease.
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Figure 3. Arachidonic acid reversibly decreases conduction along the fiber axis.
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